lawton pharmacy consultants limited Company Information
Company Number
07801116
Website
lawtonheritagerx.comRegistered Address
46 high street, lye, stourbridge, west midlands, DY9 8LQ
Industry
General medical practice activities
Telephone
01895232876
Next Accounts Due
August 2025
Group Structure
View All
Shareholders
bluecross health ltd 66.7%
aliasghar shiraz porbanderwalla 16.7%
View Alllawton pharmacy consultants limited Estimated Valuation
Pomanda estimates the enterprise value of LAWTON PHARMACY CONSULTANTS LIMITED at £849k based on a Turnover of £1.4m and 0.59x industry multiple (adjusted for size and gross margin).
lawton pharmacy consultants limited Estimated Valuation
Pomanda estimates the enterprise value of LAWTON PHARMACY CONSULTANTS LIMITED at £228.6k based on an EBITDA of £46.4k and a 4.92x industry multiple (adjusted for size and gross margin).
lawton pharmacy consultants limited Estimated Valuation
Pomanda estimates the enterprise value of LAWTON PHARMACY CONSULTANTS LIMITED at £47k based on Net Assets of £168.3k and 0.28x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Lawton Pharmacy Consultants Limited Overview
Lawton Pharmacy Consultants Limited is a live company located in stourbridge, DY9 8LQ with a Companies House number of 07801116. It operates in the general medical practice activities sector, SIC Code 86210. Founded in October 2011, it's largest shareholder is bluecross health ltd with a 66.7% stake. Lawton Pharmacy Consultants Limited is a established, small sized company, Pomanda has estimated its turnover at £1.4m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Lawton Pharmacy Consultants Limited Health Check
Pomanda's financial health check has awarded Lawton Pharmacy Consultants Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
6 Weak
Size
annual sales of £1.4m, make it in line with the average company (£1.3m)
- Lawton Pharmacy Consultants Limited
£1.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (7.3%)
- Lawton Pharmacy Consultants Limited
7.3% - Industry AVG
Production
with a gross margin of 39.5%, this company has a comparable cost of product (39.5%)
- Lawton Pharmacy Consultants Limited
39.5% - Industry AVG
Profitability
an operating margin of 2.8% make it less profitable than the average company (4.4%)
- Lawton Pharmacy Consultants Limited
4.4% - Industry AVG
Employees
with 11 employees, this is below the industry average (19)
11 - Lawton Pharmacy Consultants Limited
19 - Industry AVG
Pay Structure
on an average salary of £31.3k, the company has an equivalent pay structure (£31.3k)
- Lawton Pharmacy Consultants Limited
£31.3k - Industry AVG
Efficiency
resulting in sales per employee of £130.1k, this is more efficient (£77.7k)
- Lawton Pharmacy Consultants Limited
£77.7k - Industry AVG
Debtor Days
it gets paid by customers after 39 days, this is near the average (38 days)
- Lawton Pharmacy Consultants Limited
38 days - Industry AVG
Creditor Days
its suppliers are paid after 108 days, this is slower than average (26 days)
- Lawton Pharmacy Consultants Limited
26 days - Industry AVG
Stock Days
it holds stock equivalent to 17 days, this is more than average (7 days)
- Lawton Pharmacy Consultants Limited
7 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 17 weeks, this is less cash available to meet short term requirements (37 weeks)
17 weeks - Lawton Pharmacy Consultants Limited
37 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 69.4%, this is a higher level of debt than the average (60.2%)
69.4% - Lawton Pharmacy Consultants Limited
60.2% - Industry AVG
LAWTON PHARMACY CONSULTANTS LIMITED financials
Lawton Pharmacy Consultants Limited's latest turnover from November 2023 is estimated at £1.4 million and the company has net assets of £168.3 thousand. According to their latest financial statements, Lawton Pharmacy Consultants Limited has 11 employees and maintains cash reserves of £128.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 11 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 24,043 | 5,591 | 7,190 | 10,213 | 13,841 | 20,520 | 29,095 | 32,038 | 38,344 | 82,647 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 24,043 | 5,591 | 7,190 | 10,213 | 13,841 | 20,520 | 29,095 | 32,038 | 38,344 | 82,647 | 0 | 0 |
Stock & work in progress | 42,685 | 32,126 | 45,686 | 49,169 | 52,389 | 38,024 | 37,810 | 38,755 | 38,425 | 37,465 | 0 | 0 |
Trade Debtors | 154,696 | 140,656 | 88,965 | 149,473 | 101,898 | 74,332 | 166,488 | 159,389 | 153,341 | 369,197 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 1,157 | 1,157 | 1,157 | 1,157 | 0 | 0 | 0 | 0 |
Misc Debtors | 199,720 | 265,240 | 206,926 | 198,412 | 124,790 | 105,411 | 48,228 | 4,629 | 0 | 0 | 0 | 0 |
Cash | 128,837 | 97,501 | 110,910 | 12,302 | 103,078 | 59,932 | 2,560 | 12,623 | 16,409 | 1,785 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 525,938 | 535,523 | 452,487 | 409,356 | 383,312 | 278,856 | 256,243 | 216,553 | 208,175 | 408,447 | 0 | 0 |
total assets | 549,981 | 541,114 | 459,677 | 419,569 | 397,153 | 299,376 | 285,338 | 248,591 | 246,519 | 491,094 | 0 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 258,139 | 237,284 | 218,231 | 216,082 | 238,898 | 180,965 | 219,052 | 196,497 | 214,366 | 427,805 | 0 | 0 |
Group/Directors Accounts | 0 | 88,536 | 28,985 | 18,850 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 118,395 | 80,846 | 114,399 | 62,890 | 93,022 | 69,401 | 32,517 | 33,507 | 0 | 0 | 0 | 0 |
total current liabilities | 376,534 | 406,666 | 361,615 | 302,822 | 331,920 | 250,366 | 251,569 | 230,004 | 214,366 | 427,805 | 0 | 0 |
loans | 0 | 0 | 0 | 45,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40,000 | 50,000 | 0 | 0 |
provisions | 5,124 | 316 | 363 | 718 | 1,138 | 2,080 | 3,310 | 3,560 | 4,196 | 12,294 | 0 | 0 |
total long term liabilities | 5,124 | 316 | 363 | 45,718 | 1,138 | 2,080 | 3,310 | 3,560 | 44,196 | 62,294 | 0 | 0 |
total liabilities | 381,658 | 406,982 | 361,978 | 348,540 | 333,058 | 252,446 | 254,879 | 233,564 | 258,562 | 490,099 | 0 | 0 |
net assets | 168,323 | 134,132 | 97,699 | 71,029 | 64,095 | 46,930 | 30,459 | 15,027 | -12,043 | 995 | 0 | 0 |
total shareholders funds | 168,323 | 134,132 | 97,699 | 71,029 | 64,095 | 46,930 | 30,459 | 15,027 | -12,043 | 995 | 0 | 0 |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 6,489 | 2,974 | 3,683 | 3,628 | 9,562 | 11,989 | 11,276 | 10,448 | 15,939 | 11,535 | ||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Tax | ||||||||||||
Stock | 10,559 | -13,560 | -3,483 | -3,220 | 14,365 | 214 | -945 | 330 | 960 | 37,465 | 0 | 0 |
Debtors | -51,480 | 110,005 | -51,994 | 120,040 | 46,945 | -34,973 | 50,698 | 11,834 | -215,856 | 369,197 | 0 | 0 |
Creditors | 20,855 | 19,053 | 2,149 | -22,816 | 57,933 | -38,087 | 22,555 | -17,869 | -213,439 | 427,805 | 0 | 0 |
Accruals and Deferred Income | 37,549 | -33,553 | 51,509 | -30,132 | 23,621 | 36,884 | -990 | 33,507 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 4,808 | -47 | -355 | -420 | -942 | -1,230 | -250 | -636 | -8,098 | 12,294 | 0 | 0 |
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | 0 | 0 | -5,000 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -88,536 | 59,551 | 10,135 | 18,850 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | -45,000 | 45,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40,000 | -10,000 | 50,000 | 0 | 0 |
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | 31,336 | -13,409 | 98,608 | -90,776 | 43,146 | 57,372 | -10,063 | -3,786 | 14,624 | 1,785 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 31,336 | -13,409 | 98,608 | -90,776 | 43,146 | 57,372 | -10,063 | -3,786 | 14,624 | 1,785 | 0 | 0 |
lawton pharmacy consultants limited Credit Report and Business Information
Lawton Pharmacy Consultants Limited Competitor Analysis
Perform a competitor analysis for lawton pharmacy consultants limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in DY9 area or any other competitors across 12 key performance metrics.
lawton pharmacy consultants limited Ownership
LAWTON PHARMACY CONSULTANTS LIMITED group structure
Lawton Pharmacy Consultants Limited has no subsidiary companies.
Ultimate parent company
1 parent
LAWTON PHARMACY CONSULTANTS LIMITED
07801116
lawton pharmacy consultants limited directors
Lawton Pharmacy Consultants Limited currently has 2 directors. The longest serving directors include Mr Aliasghar Porbanderwalla (Feb 2012) and Mr Huzeifa Porbanderwalla (Mar 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Aliasghar Porbanderwalla | United Kingdom | 46 years | Feb 2012 | - | Director |
Mr Huzeifa Porbanderwalla | England | 33 years | Mar 2019 | - | Director |
P&L
November 2023turnover
1.4m
+23%
operating profit
39.9k
0%
gross margin
39.5%
+0.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
168.3k
+0.25%
total assets
550k
+0.02%
cash
128.8k
+0.32%
net assets
Total assets minus all liabilities
lawton pharmacy consultants limited company details
company number
07801116
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
October 2011
age
13
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
November 2023
address
46 high street, lye, stourbridge, west midlands, DY9 8LQ
accountant
HOWELL DAVIES LIMITED
auditor
-
lawton pharmacy consultants limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to lawton pharmacy consultants limited.
lawton pharmacy consultants limited Companies House Filings - See Documents
date | description | view/download |
---|